Delcath Systems Exceeds Q1 Revenue Estimates, Reports Net Loss
Summary
Delcath Systems reported Q1 revenue of $24.994 million, surpassing the IBES estimate of $23.4 million. While the company achieved a top-line beat, it posted a net loss of $1.07 million and an operating loss of $1.637 million for the quarter. This contrasts with the significant financial turnaround reported in its 2025 annual report, which included its first net income and positive operating cash flow. Traders will be evaluating whether the revenue growth can translate into sustained profitability, especially given the recent positive momentum.
At the time of this announcement, DCTH was trading at $11.32 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $388M. The 52-week trading range was $8.12 to $18.23. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.